Research has indicated that promyelocytic leukemia protein (PML) influences cellular proliferation and tumor inhibition through the modulation of apoptotic signals, and deactivation of PLM completely abrogates the proapoptotic ability of Daxx [53]. This evidence concerns the gene FXYD1 and neoplasm.